There are several vaccine trials ongoing across the globe, including high profile trials by Oxford University and Imperial College London. However, there is no guarantee that any of these projects will produce a useable vaccine and it is likely that no vaccine will be ready by mid-September. After being criticised at the start of the pandemic for failing to acquire enough PPE equipment to roll out to front line healthcare workers and other staff by the peak, the government and healthcare officials have moved swiftly on injection devices.
Mike Fairbourn, vice president and general manager of Becton, Dickinson and Company U.K. and Ireland said, "With a 60-year history in vaccine delivery, BD is committed to producing 65 million high-quality vaccine injection devices to support the U.K. in planning for a COVID-19 vaccination campaign. BD applauds the U.K. government for its forward-thinking and coordinated approach in planning for future COVID-19 needs. This device selection will help ensure the maximum number of U.K. citizens get inoculated in the fastest possible timeframe. We thank the government for its partnership, and we look forward to continuing to work with all levels of government in the U.K., as we partner together to respond to the COVID-19 pandemic and support the re-setting of the National Health Service as core health care work resumes."
The U.K. is among the first governments in the world to secure vaccine injection devices in support of a national COVID-19 vaccination campaign. While many annual vaccines come ready-to-deliver in prefilled syringes, due to the rapid ramp up in production and speed necessary to deploy the COVID-19 vaccination quickly, the new vaccine is anticipated to be made available initially in single or multidose vials, which require the use of separate needles and syringes to draw the vaccine from the vial and administer it to patients.BLOG COMMENTS POWERED BY DISQUS